FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) would like to congratulate High Tide Inc. (CSE: HITI) (OTCQB: HITIF) (FRA: 2LY) (“High Tide”) on the recent announcement from Alberta Gaming, Liquor and Cannabis lifting the moratorium on issuing cannabis licenses and accepting license applications. The announcement is an encouraging sign of steadily improving cannabis supply levels in Alberta and is a positive step for companies like High Tide that have numerous stores ready and waiting to retail cannabis products. read more

Rockridge Announces the Appointment of Grant Ewing as Chief Executive Officer of the Company

Rockridge Resources Ltd. (TSX-V: ROCK) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce the appointment of Grant Ewing as Chief Executive Officer of the Company. Grant Ewing is a professional geologist with over 25 years of experience in the mineral industry and the last 10+ years in senior executive roles. His extensive knowledge base covers the entire mine development cycle, from early stage exploration through to production, in several different commodities. Strong merger and acquisitions, corporate development, and capital markets knowledge complement Mr. Ewing’s mineral industry experience. read more

NexGen Intersects High-Grade Mineralization in all Twenty A2 and A3 Targets from the 2019 Feasibility Stage Drilling Program

T.NXE, NexGen, uranium
Figure 1: Arrow Deposit Drill Hole Locations (CNW Group/NexGen Energy Ltd.)

NexGen Energy Ltd. (“NexGen” or the “Company”) (TSX: NXE, NYSE MKT: NXE) is pleased to report radioactivity for an additional twenty holes comprising 7,969.5 m from the Company’s Feasibility stage drilling program at our 100% owned, Rook I property in the Athabasca Basin Saskatchewan. read more

Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), today announced the appointment of pharmaceutical industry leader, Edward J. Brennan, Jr., M.D., FACS, as President of its biosciences division. Dr. Brennan has more than 25 years’ experience in leadership roles at major pharmaceutical companies and clinical research organizations. read more

Gensource Potash: Production Module #2

Canada gold, junior mining companies

When last we spoke to Mike Ferguson, CEO of Gensource Potash (V.GSP) back in August 2017, the company had just released a full feasibility on its modular approach to potash extraction and sale. The company was taking a radically different approach to potash mining and building modules which will produce a relatively tiny 250,000 tonnes per year. The great advantage of this approach, other than a significantly lower CAPEX, is that the entire production of a module may be bought by a single end user. read more

Aben Announces Ambitious Exploration Plans for Justin Gold Project in the Yukon and Forrest Kerr Gold Project in BC’s Golden Triangle Region

Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Aben or the Company”) is pleased to provide an update on the Company’s plans for the coming 2019 drill season at the 100% owned 7,400-hectare Justin Gold Project in the Yukon and the 23,000-hectare Forrest Kerr Gold Project in the Golden Triangle region of British Columbia. This year, the Company plans to extend its drilling season one month by initiating a 2000-meter drill program at the Justin Gold Project commencing in early June. This program will entail 1350 meters of diamond drilling and 600 meters of Rotary Air Blast drilling (“RAB”), along with prospect generating field work. This program should take 3-4 weeks to complete which will coincide with the commencement of the Forrest Kerr Project 2019 drill program at the end of June. The Forrest Kerr drill program is on track to complete a planned 5000 meters but has the ability to add to the size and scope of the program if results warrant. Aben is well funded and looks forward to the onset of exploration on both of these high-quality Canada-based gold projects. read more

World Class Extractions Acquisition Target, Quadron Cannatech Introduces the “BIG BEAST” – the Latest Member of the BEAST Family of Extraction Systems to Process Over 5,000,000 kg of Cannabis or Hemp Per Year

World Class Extractions Inc. (“World Class”) (CSE: PUMP) (FRA:WCF) is pleased to announce that its acquisition target Quadron Cannatech Corporation (the “Company” or “Quadron”) (CSE: QCC), will begin to take reservations to toll process hemp or cannabis with the “BIG BEAST”, a fully automated, touch screen control continuous flow Ethanol Extractor System. The “BIG BEAST is the latest addition to the BEAST family of extractors, with estimated processing capacity of up to 20,000 kg of biomass per day – over 5,000,000 kg of biomass annually. read more

FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board

Daniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA Join distinguished group of Scientific Advisors
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), is pleased to announce that three eminent cannabis researchers have joined the company’s Scientific Advisory Board (“SAB”). read more